Literature DB >> 19522837

Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease.

J Amighi1, O Schlager, M Haumer, P Dick, W Mlekusch, C Loewe, G Böhmig, R Koppensteiner, E Minar, M Schillinger.   

Abstract

BACKGROUND: Patients with symptomatic peripheral artery disease (PAD) are considered cardiovascular high-risk patients. Our aim was to investigate whether incidental renal artery stenosis (RAS) increases the risk for adverse cardiovascular and renal outcomes in these patients.
MATERIALS AND METHODS: We prospectively enrolled 487 consecutive patients admitted for revascularization of symptomatic PAD and performed a renal overview angiogram categorizing RAS as absent (0-29%), moderate (30-59%) and severe (>or= 60%) respectively. Clinical follow-up was for median 15 months (IQR 12-22) for the occurrence of major adverse events [MAE: composite of death, myocardial infarction (MI), stroke, percutaneous coronary intervention, coronary bypass surgery, amputation and kidney failure]. Glomerular filtration rates (GFR) were obtained at 12 months to quantify the course of renal function.
RESULTS: A severe RAS was found in 76 patients (15.6%). Overall MAE occurred in 121 patients (24.8%), the composite endpoint of MI, stroke, amputation and death occurred in 101 patients (20.7%). Patients with a severe RAS had a 1.87-fold increased adjusted risk for MAE (95% CI 1.12-3.12, P = 0.017), a 2.51-fold increased adjusted risk for occurrence of the composite endpoint of MI, stroke, amputation and death (95% CI 1.45-4.34, P = 0.001) and a 2.93-fold increased risk for death (95% CI 1.41-6.08, P = 0.004), compared to those of patients without RAS respectively. We observed a significant association between the decrease of GFR over the 12-month follow-up period and the severity of RAS by multivariable analysis (P = 0.044).
CONCLUSION: Severe RAS in patients with symptomatic PAD is an independent predictor of major adverse cardiovascular events, adverse renal outcome and mortality.

Entities:  

Mesh:

Year:  2009        PMID: 19522837     DOI: 10.1111/j.1365-2362.2009.02180.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  Renal microvascular disease determines the responses to revascularization in experimental renovascular disease.

Authors:  Alejandro R Chade; Silvia Kelsen
Journal:  Circ Cardiovasc Interv       Date:  2010-06-29       Impact factor: 6.546

2.  Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertension.

Authors:  Lucas Lauder; Sebastian Ewen; Abraham Rami Tzafriri; Elazer Reuven Edelman; Thomas Felix Lüscher; Peter J Blankenstijn; Oliver Dörr; Markus Schlaich; Faisal Sharif; Michiel Voskuil; Thomas Zeller; Christian Ukena; Bruno Scheller; Michael Böhm; Felix Mahfoud
Journal:  EuroIntervention       Date:  2018-05-20       Impact factor: 6.534

Review 3.  Revascularization as a treatment to improve renal function.

Authors:  Helen V Alderson; James P Ritchie; Philip A Kalra
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-02-20

4.  Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study.

Authors:  Sophie J Bernelot Moens; Robert M Stoekenbroek; Fleur M van der Valk; Simone L Verweij; Mark J W Koelemay; Hein J Verberne; Max Nieuwdorp; Erik S G Stroes
Journal:  BMC Cardiovasc Disord       Date:  2016-11-25       Impact factor: 2.298

5.  Correlation between Renal Artery Anatomy and Hypertension: A Retrospective Analysis of 3000 Patients.

Authors:  Jiayi Shen; Lingchun Lyu; Xiaoyan Wu; Jiansong Ji; Chunlai Zeng; Shan Li; Yanan Zhao; Jian Xu; Li Lin; Chenyin Lu; Wei Mao; Tiemin Wei
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-29       Impact factor: 2.629

6.  A prediction model for renal artery stenosis using carotid ultrasonography measurements in patients undergoing coronary angiography.

Authors:  Yonggu Lee; Jeong-Hun Shin; Hwan-Cheol Park; Soon Gil Kim; Seong-il Choi
Journal:  BMC Nephrol       Date:  2014-04-14       Impact factor: 2.388

Review 7.  Atherosclerotic renovascular disease - epidemiology, treatment and current challenges.

Authors:  Diana Vassallo; Philip A Kalra
Journal:  Postepy Kardiol Interwencyjnej       Date:  2017-09-25       Impact factor: 1.426

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.